Fluidigm Singapore launches Biomedical Product Development Centre

Singapore R&D center to develop life science instruments targeted for US$650 million market

05-Feb-2007

Fluidigm accelerates its R&D and manufacturing activities in Singapore, through the launch of its new Biomedical Product Development Center. This center, a core part of Fluidigm's worldwide R&D organization, will be responsible for the full development of a Fluidigm BioMark II series of instrumentation.

The center's initial research activities will support the development of instrumentation for the BioMark II system. The Singapore research group will undertake 100% of the R&D on a new biochip fluorescence reader and biochip loader, specially designed for high-throughput genotyping and protein expression applications. Fluidigm Singapore will also manufacture the BioMark II system.

Operations for the Biomedical Product Development Center will commence immediately, with its current R&D team of 5. Additional staff will be recruited from Singapore's pool of manufacturing and research expertise. The R&D center will also be supported by the local precision engineering companies, academic, biomedical and pharmaceuticals research institutions.

Other news from the department manufacturing

More news from our other portals